LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in […]

LYON, FRANCE — The anti-obesity drug semaglutide is associated with significant reductions in the inflammatory marker high-sensitivity C-reactive protein (CRP), even in patients who do not […]

A work group convened by the Alzheimer’s Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer’s disease (AD), including a new biomarker […]

Dietary trends away from dairy products, plus the increasing popularity of plant-based alternative milks, have contributed to an increased risk for iodine deficiency across Europe, according […]

Baylor St. Luke’s Medical Center, Baylor College of Medicine (BCM), and Surgical Associates of Texas PA have jointly agreed to pay $15 million to resolve claims […]

The US Surgeon General has called for a warning label on social media platforms, citing research that points to a link between social media use and […]

LYON, France — The first oral small molecule anti–proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor appears to be effective in not only lowering low-density lipoprotein […]

The prevalence of vision-threatening retinopathy in people with diabetes has increased exponentially in the past decade, most acutely among younger adults and Hispanic and Black populations, […]

VIENNA — People with spondyloarthritis (SpA) who have low or stable disease activity can effectively and safely be managed using a model of patient-initiated care with […]